Innate Immunotherapeutics, the Australian biotech firm whose largest shareholder is Buffalo, N.Y.-area congressman Chris Collins, said it expects to close after its multiple sclerosis drug failed in trials.
After a Kaiser Health News report on an offshore herpes vaccine trial that skirted FDA regulations, St. Kitts and Nevis officials claim they had no knowledge of the testing. An investigation is underway.
El ensayo clínico de una vacuna contra el herpes común fuera de los Estados Unidos ha generado una controversia médica y una investigación gubernamental.
Prominent businessmen and an American university supported offshore testing of an experimental vaccine.
Among hurdles: Older adults may have multiple illnesses that could complicate research or they might be unable to manage the commute.
Innate Immunotherapeutics, whose largest shareholder is Buffalo-area Rep. Chris Collins, received FDA approval to begin U.S. trials of its drug for treating advanced multiple sclerosis.
Researchers, who detail the women’s experiences in the New England Journal of Medicine, say it exposes the need for better regulation of clinical trials.
Rep. Chris Collins’ enthusiastic investments in Australian biotech company Innate Immunotherapeutics preceded share purchases by the Buffalo Republican’s family members, associates and political donors — raising questions from Washington, D.C., to Sydney.
Pricey and unproven therapies that sound too good to be true probably are.
Researchers examine the Food and Drug Administration’s “revolving door” regarding employees who worked on cancer and hematology drugs.
Some clinics on NIH’s website charge people to participate in testing of unproven treatments — and it can come as a surprise to unsuspecting patients.
California is the first state to begin building an up-to-date database to improve the diagnosis and treatment of cancer.
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, recently spoke with KHN’s Carmen Heredia Rodriguez about vaccine development and the ongoing fight in Congress over emergency funding.
Despite the usual view that physicians are slow to alter their routines based on new scientific evidence, researchers found that breast cancer surgeons quickly adopted advice to not remove lymph nodes after a landmark clinical trial in 2011.
Treatments marketed as everything from anti-aging applications to therapies for degenerative diseases are increasingly available at commercial clinics in the U.S., but their growing numbers raise ethical and regulatory concerns in the scientific community.
The Food and Drug Administration has introduced a simplified form that doctors will use to seek FDA approval to treat seriously ill patients with experimental drugs after other options run out.
Experimental drugs might help desperate patients, but don’t count on an easy cure.
Clinical trials should look at whether men and women are affected differently, but the NIH isn’t holding researchers accountable, a new report says.
A federal institute created by the health law is seeding research projects around the U.S. that connect medical professionals with patients to find better treatments.
Insurance generally covers routine costs patients encounter in a clinical trial, but the patients can still be responsible for co-payments and other expenses, such as lost wages and travel.